New discoveries in genetics and genetic technologies are leading to innovative and personalized applications of genetic medicine. The Division of Medical Genetics and Genomic Medicine is committed to being at the forefront of discovery and translating our research into opportunities for better health. That commitment is founded in balancing comprehensive services that transcend genetic sub-specialties with research, which we believe makes our division unique from other institutions.
Our research projects include studies to improve the diagnosis and treatment of forms of congenital heart disease, pulmonary arterial hypertension, leukemia, idiopathic pulmonary fibrosis, growth hormone deficiency, scoliosis, and metabolic disorders such as phenylketonuria, lysosomal storage disorders and genetics of drug interactions with our genes.
The division provides pre-doctoral training in our T32 training program and post-doctoral training through the following programs:
The Vanderbilt Center for Undiagnosed Diseases brings together clinical and research experts from across Vanderbilt University Medical Center and the world to solve patient's most challenging medical mysteries. Vanderbilt University Medical Center is one of seven medical centers around the country in the Undiagnosed Diseases Network (UDN), a clinical research initiative of the National Institutes of Health.
Comprehensive clinical services at Monroe Carell Jr. Children's Hospital at Vanderbilt and our consultation expertise have made our division the region’s primary center for a broad spectrum of genetic and metabolic services for both children and adults.
Last Edited: August 5, 2016